David Nikodem
Chief Executive Officer chez ALTHEADX INC
Profil
David Nikodem is currently the Chief Executive Officer & Director at AltheaDx, Inc. He is also the Vice President-US Operations at Inventiva SA. Additionally, he is a Member at Sapidus Consulting Group LLC.
Previously, he worked as a Director at BNP Paribas Securities Corp.
from 2005 to 2007.
He also served as an Independent Director at Alzheon, Inc., a Director at Tunitas Therapeutics, Inc., and a Director at CG Oncology, Inc. Prior to that, he was an Analyst at Blumberg Capital Management LLC from 2002 to 2005.
He also worked as a Portfolio Manager at Exane Asset Management SA. Dr. Nikodem completed his undergraduate degree at the University of Virginia and holds a doctorate from Georgetown University.
Postes actifs de David Nikodem
| Sociétés | Poste | Début |
|---|---|---|
| ALTHEADX INC | Chief Executive Officer | 01/12/2018 |
| INVENTIVA | Corporate Officer/Principal | 01/09/2018 |
| Sapidus Consulting Group LLC | Corporate Officer/Principal | - |
Anciens postes connus de David Nikodem
| Sociétés | Poste | Fin |
|---|---|---|
BNP Paribas Securities Corp.
 BNP Paribas Securities Corp. Investment Banks/BrokersFinance BNP Paribas Securities Corp. engages in the provision of brokerage services. It offers commercial banking, corporate and institutional banking, asset management, fleet services, and real estate. The company was founded on September 7, 1984 and is headquartered New York, NY. | Trading-Equity | 30/12/2007 |
Blumberg Capital Management LLC
 Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | Analyst-Equity | 31/08/2005 |
Tunitas Therapeutics, Inc.
 Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Director/Board Member | - |
| CG ONCOLOGY, INC. | Director/Board Member | - |
| ALZHEON, INC. | Director/Board Member | - |
Formation de David Nikodem
| University of Virginia | Undergraduate Degree |
| Georgetown University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CG ONCOLOGY, INC. | Health Technology |
| INVENTIVA | Health Technology |
| Entreprise privées | 7 |
|---|---|
BNP Paribas Securities Corp.
BNP Paribas Securities Corp. Investment Banks/BrokersFinance BNP Paribas Securities Corp. engages in the provision of brokerage services. It offers commercial banking, corporate and institutional banking, asset management, fleet services, and real estate. The company was founded on September 7, 1984 and is headquartered New York, NY. | Finance |
AltheaDx, Inc.
 AltheaDx, Inc. Pharmaceuticals: MajorHealth Technology AltheaDx, Inc. operates as a commercial stage molecular diagnostics company which specializes in pharmacogenetics. It focuses in depression and anxiety, clinical publications, and IDgenetix testing process. The company was founded by Francois Ferre and Magda Marquet and is headquartered in San Diego, CA. | Health Technology |
Alzheon, Inc.
 Alzheon, Inc. BiotechnologyHealth Technology Alzheon, Inc. engages in the provision of medical development. It specializes in treatment for brain health, memory, and aging. It offers ALZ-801, an oral small molecule inhibitor of amyloid formation and neurotoxicity with potential to be a therapy for a genetically defined population of patients with or at high risk for Alzheimer's disease and other neurodegenerative disorders. The company was founded by Martin Tolar in June 2013 and is headquartered in Framingham, MA. | Health Technology |
Blumberg Capital Management LLC
Blumberg Capital Management LLC Investment ManagersFinance Blumberg Capital Management LLC is a hedge fund manager located in New York City. | Finance |
Exane Asset Management SA
 Exane Asset Management SA Investment ManagersFinance Exane Asset Management SA (Exane AM) is an alternative investment management firm headquartered in Paris, France. The firm was founded in 2001 and is a subsidiary of Exane SA, itself a subsidiary of BNP Paribas SA (EPA: BNP) in France. Exane AM manages a range of long/short equity market neutral funds designed to respond to the varied needs of a diversified European clientele, composed chiefly of institutional investors, multi-fund managers and private banking professionals. | Finance |
Tunitas Therapeutics, Inc.
Tunitas Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Tunitas Therapeutics, Inc. develops protein therapeutics for the treatment of allergy. The firm’s therapeutic approach offers the potential for long-lasting treatments with improved efficacy than existing therapies for many serious allergic diseases, such as asthma and food allergy. The company was founded by Nolan H. Sigal and Andrew Saxon in 2008 and is headquartered in San Francisco, CA. | Health Technology |
| Sapidus Consulting Group LLC |
